Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
- PMID: 32354772
- PMCID: PMC7456545
- DOI: 10.1136/annrheumdis-2020-217362
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
Keywords: antirheumatic agents; arthritis, infectious; biological therapy; spondylitis, ankylosing; tumour necrosis factor inhibitors.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Correspondence on 'Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab'.Ann Rheum Dis. 2021 May;80(5):e79. doi: 10.1136/annrheumdis-2020-218029. Epub 2020 Aug 18. Ann Rheum Dis. 2021. PMID: 32816688 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources